ZAS Corporation(Mfg. by: Thymoorgan Pharmazie GmbH,Germany)
Additional OffersShow all
Gemcitabine PhaRes may cause excessive drowsiness with alcohol.
Gemcitabine PhaRes is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescr... View More
Gemcitabine PhaRes is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Gemcitabine PhaRes may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
There is limited information available on the use of Gemcitabine PhaRes in patients with kidney disease. Please consult your doctor. Kidney function tes... View More
There is limited information available on the use of Gemcitabine PhaRes in patients with liver disease. Please consult your doctor.
Gemcitabine PhaRes is used in the treatment of non-small cell lung cancer, breast cancer, pancreatic cancer, urinary bladder cancer, and ovarian cancer.... View More
Uses of Gemcitabine PhaRes
- Non-small cell lung cancer
- Breast cancer
- Pancreatic cancer
- Urinary bladder cancer
- Ovarian cancer
Side effects of Gemcitabine PhaRes
- Loss of appetite
- Hair loss
- Low blood platelets
- Allergic reaction
- Decreased white blood cell count
- Increased liver enzymes
- Anemia (low number of red blood cells)
- Flu-like symptoms
- Blood in urine
- Skin rash
- Protein in urine
How to use Gemcitabine PhaRes
Your doctor or nurse will give you this medicine. Kindly do not self administer.
How Gemcitabine PhaRes works
Gemcitabine PhaRes interferes with the growth of DNA and RNA of the cancer cells by substituting their building blocks. It prevents the cancer cells fro... View More
- Use a reliable contraceptive method to prevent pregnancy while you are taking this medicine.
- Inform your doctor immediately if you notice any signs of infection such as fever, sore throat, rash or severe diarrhea.
Lung cancer, pancreatic cancer, bladder cancer, breast cancer, ovarian carcinoma
IV Preparation Reconstitute 200 mg vial with 5 mL 0.9% NaCl OR 1000 mg vial with 25 mL 0.9% NaCl IV Administration For IV infusion only Concentrat... View More
Pancreatic Cancer Indicated as first-line treatment for locally advanced (nonresectable Stage II or Stage III) or metastatic (Stage IV) adenocarcinoma ... View More
Concurrent radical radiotherapy; pregnancy, lactation; hypersensitivity.
Mode of Action
Gemcitabine is a synthetic pyrimidine nucleoside and cytarabine analogue which is metabolised intracellularly to active diphosphate and triphosphate nuc... View More
Children, hepatic and renal impairment. May impair ability to drive or operate machinery. Discontinue on 1st sign of microangiopathic haemolytic anaemia... View More
>10% N/V (69%),Anemia (65%),Elev LFTs (68%),Neutropenia (63%),Leukopenia (62%),Pain (48%),Proteinuria (45%),Fever (41%),Hematuria (35%),Rash (30%),Thro... View More
May increase the anticoagulant effect of warfarin when used together.
Alternative brand for Gemcitabine PhaRes
The information provided herein is accurate, updated and complete as per the best practices of the Company. Please note that this information should not... View More